Valbiotis SA (ALVAL.PA)
2.01EUR
10 Dec 2019
-- (--)
€2.01
--
--
--
--
9,152
€4.25
€1.98
Latest Key Developments (Source: Significant Developments)
Valbiotis Reports H1 Operating Loss Of 2.6 Million Euros
Aug 30 (Reuters) - Valbiotis SA
Valbiotis Obtains The European Patent For VALEDIA
Feb 11 (Reuters) - VALBIOTIS SAS
Valbiotis Initiates The Clinical Development Of Valediatm In The United-States With The Reverse-It Clinical Study
Valbiotis SAS
Valbiotis Appoints Christine Roy-Duval As Director Of Development And Medical Affairs
March 21 (Reuters) - VALBIOTIS SAS